Genesis Research and Development Corporation (GEN)

Shares / Stock Code

GEN

Stock Exchange / Sharemarket

Australian Securities Exchange

Genesis Research and Development Corporation (GEN) is a biotechnology company with core technical expertise in the fields of genomics and immunology. GEN has developed an integrated research and discovery platform that includes proprietary sets of EST databases and microRNA libraries, extensive bioinformatics capability and cell-based screening technologies to identify novel targets for drug development

The company is one of Australia's largest publicly listed biotechnology companies. GEN operates from the early discovery end of the spectrum to Phase II Clinical Trials. Its core technical expertise is in genomics and immunology whilst its primary disease targets are inflammatory or atopic disorders of skin (psoriasis, aptopic dermatitis), lung (asthma), autoimmunity (lupus), tuberculosis and some cancers.

Major competitors include other integrated research and discovery companies that have extensive bioinformatic capabilities and cell screening technologies to identify novel targets for drug development. Customers include strong working relationships with multinational pharmaceutical and biotechnology companies as well as companies in life science industries.

Genesis Research and Development Corporation History

Genesis was founded in 1994 and listed on the ASX in September 2000. The company is also listed on the New Zealand Stock Exchange. 'AgriGenesis' is a wholly owned subsidiary. Its R&D programs develop commercial applications of plant science, including bioenergy, biopolymers and biologistics.

Genesis Research and Development Corporation (GEN) Products and Services

  • Biotechnology

Genesis Research and Development Corporation (GEN) Locations and Subsidiaries

Genesis Research and Development Corporation Head Office
One Fox Street, Parnell,
AUCKLAND, NEW ZEALAND 1052
Phone: +64 9 373 5600
Fax: +64 9373 2189

Genesis Research and Development Corporation (GEN) Share Price

Submitted by ASX Listed Company on 25 March, 2010 - 22:55

Download our FREE App


Signup for Free
Don't miss out on your free share trading articles.


Free Risk Money Management Calculator for those who sign up!